(Q33942782)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Clinical use of dornase alpha is associated with a slower rate of FEV1 decline in cystic fibrosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

Michael W Konstan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Jeffrey S Wagener

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Stefanie J Millar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Joan R Jacobs

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Ashley Yegin

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Wayne J Morgan

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Scientific Advisory Group and Investigators and Coordinators of Epidemiologic Study of Cystic Fibrosis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

24 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

published in

Pediatric Pulmonology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

545-553

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

Clinical use of Ibuprofen is associated with slower FEV1 decline in children with cystic fibrosis

26 January 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109161

Mortality of cystic fibrosis patients treated with tobramycin solution for inhalation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109161

Estimating effectiveness in an observational study: a case study of dornase alfa in cystic fibrosis. The Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109161

Spirometric reference values from a sample of the general U.S. population

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109161

Effect of high-dose ibuprofen in patients with cystic fibrosis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109161

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109161

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4109161

Current understanding of the inflammatory process in cystic fibrosis: onset and etiology

5 July 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21388

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21388

Pulmonary function between 6 and 18 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21388

Relationship between inhaled corticosteroid therapy and rate of lung function decline in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21388

Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21388

Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21388

Factors influencing outcomes in cystic fibrosis: a center-based analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21388

Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPPUL.21388

Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21438174

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Epidemiologic study of cystic fibrosis: design and implementation of a prospective, multicenter, observational study of patients with cystic fibrosis in the U.S. and Canada

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21438174

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifying treatments that halt progression of pulmonary disease in cystic fibrosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21438174

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/PPUL.21388

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21438174%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference